Corporate Complicity Index
CCI

Company Directory

Company Directory

Company Directory - Sangamo Therapeutics, Inc.

Company Details - Sangamo Therapeutics, Inc.

Sangamo Therapeutics, Inc. Logo

Sangamo Therapeutics, Inc.

Website

NASDAQ: SGMO 

Sangamo Therapeutics is a biotechnology company that focuses on gene therapy, gene editing, and other related technologies.

CCI Score

CCI Score: Sangamo Therapeutics, Inc.

-41.02

0.02%

Latest Event

Sangamo Announces Layoffs of 120 Workers Amid Pipeline Restructuring

Sangamo Therapeutics announced a 27% reduction in its workforce, cutting approximately 120 jobs as part of a strategic pipeline restructuring to focus on select research programs. This move has raised concerns over the company’s labor practices and the impact on worker security.

Take Action

So what can you do? It's time to make tough choices. Where will you cast your vote?

Shop Alternatives
SEE ALL
Baker Institute
CRISPR Therapeutics
TransCode
Use Your Voice
OTHER TOOLS
Investigate
Share the Score
SUPPORT CCI

TOADIE

Sangamo Therapeutics, Inc. is currently rated as a Toadie.

-30 to -44 CCI Score
Companies scoring in this range actively seek to please authoritarian regimes. They offer proactive support and assistance in exchange for preferential treatment, compromising ethical standards for business gains and political favor.

Latest Events

  • Sangamo Announces Layoffs of 120 Workers Amid Pipeline Restructuring Logo
    APR
    27
    2023
    Sangamo Announces Layoffs of 120 Workers Amid Pipeline Restructuring

    -41.02

    Sangamo Therapeutics announced a 27% reduction in its workforce, cutting approximately 120 jobs as part of a strategic pipeline restructuring to focus on select research programs. This move has raised concerns over the company’s labor practices and the impact on worker security.

  • -50

    Labor Relations and Human Rights Practices

    April 3

    The company's decision to lay off 120 employees, representing a significant 27% cut in its workforce, negatively affects worker rights and job security. From an anti-fascist perspective, such measures undermine labor stability and are seen as prioritizing cost-saving over ethical responsibility to employees.

    Sangamo to lay off 120 as it pares pipeline

Industries

325414
Biological Product (except Diagnostic) Manufacturing
541714
Research and Development in Biotechnology (except Nanobiotechnology)
541715
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)